SUBSTRATES FOR METALLOENDOPEPTIDASES IN THE CENTRAL NERVOUS SYSTEM
SUBSTRATES FOR METALLOENDOPEPTIDASES IN THE CENTRAL NERVOUS SYSTEM
复制标题
DOI:
10.1142/9781860947179_0004
复制
发表时间:
2005-01-01
期刊:
影响因子:
--
通讯作者:
Zimmermann, D. R.
中科院分区:
文献类型:
--
作者:
Gottschall, P. E.;Sandy, J. D.;Zimmermann, D. R.
The matrix metalloproteinases (MMPs) and related matrix-degrading metalloendopeptidases (ADAMTSs and ADAMs) most often appear in physiology and pathology during events related to cell and tissue remodelling, and function per their name, in the cleavage and/or degradation of extracellular matrix (ECM) proteins as well as non-matrix protein substrates. Other sources including chapters in this volume have delineated the fact that MMPs are important modulators of key functions in the nervous system from progenitor migration during development, to differentiation of glial cells, to enhancing axonal sprouting (1, 2). Yet the crucial role for metalloendopeptidases in developmental physiology somewhat belies their potential for tissue destruction in various neuropathologies in the adult ranging from multiple sclerosis to cerebrovascular stroke to Alzheimer’s disease. In this regard, however, it should be noted that even in the adult nervous system, the actions of metalloendopeptidases are clearly not confined to pathological effects. Yet, how do proteolytic enzymes that primarily act outside cells, most often by binding to and cleaving matrix substrates, influence cell behaviour? Although metalloendopeptidases may directly activate intracellular signalling pathways via ‘receptors’, their